Home » Newsletters » BioWorld Science

BioWorld Science

July 23, 1997

View Archived Issues

Recombinant infertility drug launched in Canada

U.K. approves Astra's treatment for ulcerative colitis

FINFAT multicenter trial results reported at IDF 97

Troglitazone clinical data presented at IDF 97

Problems of insulin supply: insulin turns 75

Novartis prepares orally active iron chelators

Schering AG describes AMPA antagonists

Inhibitors of adhesion molecule expression and TNF release from Novartis

Warner-Lambert describes compounds that modulate signal transduction pathways

TZT-1027 exhibits promising preclinical profile

Pharmacokinetics of S-1 in tumor-bearing animals

Ritipenem acoxil: biliary excretion and efficacy in surgical infections

Interactions between LY-303366 and nikkomycin Z against fungi

Teva's generic antihypertensive combination tentatively approved

Preclinical and clinical results reported for cefluprenam, a new parenteral cephalosporin

Life Medical Sciences discontinues venous stasis ulcer trial

Naratriptan approved in 10 additional European countries

Diabetes: an epidemic for the 21st century

Update on Sugen's SU-101

Hepatic insulin gene expression for treatment of IDDM

Annual Report: Genetronics

Genome Therapeutics and Astra Research Center Boston extend H. pylori alliance

Emitefur: phase II results in breast, gastric and pancreatic cancer

The Immune Response Corp. reports on T-cells involved in psoriasis

IDEC acquires anticancer agent from Pharmacia & Upjohn

Roche licenses patent rights for interferon alfa to Amarillo Biosciences

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...